drugset / Trial / NCT01422369
Drug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin
Non-randomizedSingle-groupOpen-label
Summary
This is a Phase 4, single center, open label, fixed-sequence, multiple dose, 2-way drug-drug interaction study.
Timeline
- Start
- 2011-04
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darunavir | Small molecule | 800 mg | — |
| Subject | Pitavastatin | Small molecule | 4 mg | — |
| Subject | Ritonavir | Other / unclassified | 100 mg | — |
Indications
No indication recorded.